Vascular Access Devices Market Size, Share & COVID-19 Impact Analysis-United States-2023-2029-MedSuite-Includes: Implantable Ports, Port Needles, Central Venous Catheters, and 12 more
The U.S. market for vascular access devices and accessories reached a valuation of $5.2 billion in 2022. The market is anticipated to increase at a CAGR of 2.5% to reach a value of $6.2 billion during the forecast period.
The comprehensive report suite covering the U.S. market for vascular access devices and accessories includes a wide range of products, such as implantable ports, port needles, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), peripheral intravenous catheters (PIVCs), midlines, extended dwell catheters (EDCs), dialysis catheters, ultrasound machines specialized for vascular access, vein visualization devices, tip-placement devices, catheter securement devices, antibacterial catheter patches, catheter caps, syringes, and needles.
DATA TYPES INCLUDED
Unit Sales, Average Selling Prices, Market Value & Growth Trends
Vascular Access Procedure Volumes
Market Forecasts Until 2029, and Historical Data to 2019
Competitive Analysis with Market Shares for Each Segment
Market Drivers & Limiters for Each Vascular Access Device market
Recent Mergers & Acquisitions
COVID19 Impact on the US Vascular Access and Accessories market
Disease Overviews and Demographic Information
Company Profiles, Product Portfolios, and SWOT for Top Competitors
U.S. VASCULAR ACCESS MARKET INSIGHTS
As a result of the complications and concerns linked to PICCs, the market is shifting towards more cost-effective catheter devices with lower failure rates. Two alternatives that are gaining popularity are midlines and extended dwell catheters, which are shorter and can be placed in peripheral veins to minimize the risk of infection and complications. Innovative technologies have been developed to enhance the dwell time and decrease failure rates of PIVCs, potentially reducing the number of catheters needed per patient. These advancements incorporate antimicrobial coatings, improved catheter materials, and enhanced insertion techniques.
U.S. VASCULAR ACCESS MARKET SHARE INSIGHT
Becton Dickinson, 3M, and Teleflex currently dominate the U.S. vascular access device market. However, the market has been shifting towards less expensive catheter devices with lower failure rates due to the complications and concerns associated with PICCs. Midlines and extended dwell catheters have emerged as popular alternatives that are gaining traction as they are shorter and can be placed in peripheral veins to reduce the risk of infection and complications. New technologies, such as antimicrobial coatings, better catheter materials, and improved insertion techniques, have been developed to improve the dwell time and reduce failure rates of PIVCs, resulting in fewer catheters being required per patient.
MARKET SEGMENTATION SUMMARY
Implantable Port Market – MedCore
Port Needle Market – MedCore
Central Venous Catheter Market – MedCore
Peripherally Inserted Central Catheter Market – MedCore
Peripheral Intravenous Catheter Market – MedCore
Midline Market – MedCore
Extended Dwell Catheter Market – MedCore
Dialysis Catheter Market – MedCore
Vascular Access Ultrasound Market – MedCore
Vein Visualization Device Market – MedCore
Tip-placement Device Market – MedCore
Catheter Securement Device Market – MedCore
Antibacterial Catheter Patch Market – MedCore
Catheter Cap Market – MedCore
Syringe and Needle Market – MedCore
RESEARCH SCOPE SUMMARY
Regions : North America (United States)
Base Year: 2022
Forecast Period: 2023-2029
Historical Data: 2019-2022
Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices
Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
WHY CHOOSE IDATA?
Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook